NL-OMON23598招募中不适用
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST)
ZonMW, Dutch Heart Foundation0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- •Patient is 18 years of age or older
- •Patient is able and willing to give their consent and sign an informed consent
- •Patient has a symptomatic or asymptomatic atherosclerotic carotid artery stenosis of at least 50% narrowing of the lumen (calculated by using criteria equivalent to the NASCET method) wherefore revascularisation through carotid endarterectomy is planned routinely.
排除标准
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •Previous anaphylactic reaction (e.g. food allergy, medication such as antibiotics etc.)
- •Previous CEA or CAS in the ipsilateral artery
- •Patients with severe asthma or chronic urticaria which are treated or have been treated with omalizumab s.c.
研究者
相似试验
进行中（未招募）
1 期
Medication for inhibition of activation of a certain immune cell in atherosclerotic lesionsAtherosclerosisEUCTR2019-002452-16-NLMC Utrecht80
进行中（未招募）
1 期
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST)MedDRA version: 24.1Level: LLTClassification code: 10029992Term: Occlusion and stenosis of carotid artery Class: 10029205MedDRA version: 21.1Level: LLTClassification code: 10081245Term: External carotid artery stenosis Class: 10029205MedDRA version: 20.0Level: PTClassification code: 10007687Term: Carotid artery stenosis Class: 100000004852MedDRA version: 21.1Level: LLTClassification code: 10081244Term: Internal carotid artery stenosis Class: 10029205Carotid artery stenosisCTIS2024-513581-19-00niversitair Medisch Centrum Utrecht40
尚未招募
2 期
Inhibition of Mast cell Activation in AtheroScleroTic lesions using an Anti-IgE antibody approach (MAST-trial)carotid narrowingatherosclerotic carotid artery stenosis10003216NL-OMON54785niversitair Medisch Centrum Utrecht80
Unknown
4 期
Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic LesionsAtherosclerosisNCT00640744Baylor College of Medicine12
招募中
4 期
Stabilization of vulnerable atherosclerotic carotid plaques by Rivaroxaban as evaluated by 3D contrast enhanced ultrasound (CEUS)2024-518539-13-00Rigshospitalet62